More Information about Clinical Studies evaluating IMM-101

For more information about ongoing studies with IMM-101, please see below:

MEPANC-1, oligo metastatic pancreatic cancer (Netherlands)

ANTONIO, Stage III Colorectal Cancer (Germany)


Clinical Trials

We cannot legally provide individual advice concerning the benefits of IMM-101. Your physician/medical team would need to make contact with the relevant trial Principal Investigator whose details, together with other information regarding our clinical trials, can be found on


IMM-101 is an unlicensed product that is only available for use in appropriately authorised clinical trials.

Some Advocacy Groups